Wondfo Biotech to cancel restricted stocks, reduce capital
Guangzhou Wondfo Biotech announced plans to cancel its 2024 restricted stock incentive plan and reduce registered capital following approval at a shareholder meeting on July 4, 2025. The decision stems from significant changes in the company’s internal and external environment since the plan’s inception, which have led to deviations in projected performance targets. Consequently, the company will repurchase and cancel 1,054,400 restricted shares that were granted but remain subject to restrictions. With the cancellation of the incentive plan, the related assessment measures will also terminate. Creditors have 45 days to request debt repayment or guarantees from the date of announcement.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Guangzhou Wondfo Biotech publishes news
Free account required • Unsubscribe anytime